Molecular Templates Inc
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for th… Read more
Molecular Templates Inc (MTEM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.824x
Based on the latest financial reports, Molecular Templates Inc (MTEM) has a cash flow conversion efficiency ratio of -0.824x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.86 Million) by net assets ($7.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Molecular Templates Inc - Cash Flow Conversion Efficiency Trend (2002–2023)
This chart illustrates how Molecular Templates Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Molecular Templates Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Molecular Templates Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
One2tribe S.A.
WAR:O2T
|
N/A |
|
Aperture Health Inc
PINK:ELNX
|
N/A |
|
Bluefire
PINK:BLFR
|
-0.002x |
|
OLYMPIA CAPITAL HOLDINGS LTD
XNAI:OCH
|
N/A |
|
Enka de Colombia S.A.: ENKA
CM:ENKA
|
N/A |
|
Alfalah Consumer
KAR:ACIETF
|
N/A |
|
KTL GLOBAL
BE:5K1
|
-0.215x |
|
Autins Group plc
LSE:AUTG
|
0.011x |
Annual Cash Flow Conversion Efficiency for Molecular Templates Inc (2002–2023)
The table below shows the annual cash flow conversion efficiency of Molecular Templates Inc from 2002 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $4.21 Million | $-41.82 Million | -9.929x | -268.77% |
| 2022-12-31 | $-15.13 Million | $-89.02 Million | 5.883x | +1371.27% |
| 2021-12-31 | $65.66 Million | $-30.39 Million | -0.463x | +67.23% |
| 2020-12-31 | $59.34 Million | $-83.80 Million | -1.412x | -476.34% |
| 2019-12-31 | $103.03 Million | $-25.24 Million | -0.245x | -453.73% |
| 2018-12-31 | $100.91 Million | $-4.46 Million | -0.044x | +76.02% |
| 2017-12-31 | $77.29 Million | $-14.26 Million | -0.185x | +85.38% |
| 2016-12-31 | $19.89 Million | $-25.10 Million | -1.262x | -35.64% |
| 2015-12-31 | $40.85 Million | $-38.00 Million | -0.930x | -180.43% |
| 2014-12-31 | $-23.98 Million | $-27.73 Million | 1.157x | +367.52% |
| 2013-12-31 | $-23.48 Million | $10.15 Million | -0.432x | +79.97% |
| 2012-12-31 | $-13.85 Million | $29.91 Million | -2.159x | +59.41% |
| 2011-12-31 | $4.48 Million | $-23.85 Million | -5.320x | -17.49% |
| 2010-12-31 | $4.94 Million | $-22.38 Million | -4.528x | -476.89% |
| 2009-12-31 | $22.66 Million | $-17.79 Million | -0.785x | -3.07% |
| 2008-12-31 | $21.41 Million | $-16.31 Million | -0.762x | +48.99% |
| 2007-12-31 | $19.59 Million | $-29.25 Million | -1.493x | -42.28% |
| 2006-12-31 | $44.24 Million | $-46.42 Million | -1.049x | -213.87% |
| 2005-12-31 | $89.37 Million | $-29.88 Million | -0.334x | -181.95% |
| 2004-12-31 | $-26.47 Million | $-10.80 Million | 0.408x | -40.60% |
| 2003-12-31 | $-9.70 Million | $-6.66 Million | 0.687x | -25.81% |
| 2002-12-31 | $-2.67 Million | $-2.47 Million | 0.926x | -- |